Viveve Medical (VIVE) Stock Price, News & Analysis

Company Overview

Viveve Medical is a global medical technology company that develops and markets non‐invasive solutions for women’s intimate health. Its flagship offering, the Viveve System, utilizes cryogen‐cooled monopolar radiofrequency energy to stimulate collagen remodeling in vaginal tissue. This proprietary technology is designed to address conditions such as vaginal laxity and stress urinary incontinence, with the goal of improving comfort, sensitivity and overall quality of life for adult women.

Since its founding in 2010, the company has secured regulatory clearances for the Viveve System in major markets including the United States, Canada, Australia, Japan and several countries in Europe. Clinical studies conducted across multiple geographies have demonstrated safety and efficacy in enhancing tissue firmness and reducing symptoms associated with pelvic floor weakness. Viveve Medical also collaborates with leading research institutions to expand its product portfolio and explore additional applications of its radiofrequency platform.

Headquartered in Bothell, Washington, Viveve Medical operates through a combination of direct sales and distributor partnerships to reach physicians in dermatology, gynecology and urology practices worldwide. The company is led by Chief Executive Officer Robert McNally, whose background spans medical device commercialization and global strategy. Under his guidance, Viveve continues to invest in clinical research, physician training programs and marketing initiatives aimed at expanding patient access to its women’s health technologies.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 3,146 shs
• Market Capitalization: $1 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VIVE Stock Analysis - Frequently Asked Questions

How were Viveve Medical's earnings last quarter?

Viveve Medical, Inc. (NASDAQ:VIVE) posted its quarterly earnings results on Thursday, November, 11th. The company reported ($0.67) earnings per share for the quarter, missing analysts' consensus estimates of ($0.58) by $0.09. The business had revenue of $1.62 million for the quarter.

When did Viveve Medical IPO?

Viveve Medical (VIVE) raised $13 million in an initial public offering on Tuesday, June 14th 2016. The company issued 1,600,000 shares at $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

How do I buy shares of Viveve Medical?

Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), NIO (NIO) and Western Digital (WDC).

Company Calendar

• Last Earnings: 11/11/2021
• Today: 7/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:VIVE
• Previous Symbol: OTCMKTS:PLCSD
• CIK: 879682
• Web: www.viveve.com
• Phone: (720) 696-8100
• Fax: 720-696-8199
• Employees: 70
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $6.83 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 10,670,000
• Free Float: N/A
• Market Cap: $1 thousand
• Optionable: Not Optionable
• Beta: 0.14